LifeSciences BC > News > Member Announcements > Page 2

2019 LifeSciences BC Annual Award Winners Announced

February 20, 2019
LifeSciences BC

VANCOUVER, BC – February 20, 2019 – LifeSciences BC is pleased to announce the recipients of the 21st Annual LifeSciences BC Awards, presented by FARRIS. These awards are presented annually to recognize talented individuals and organizations that represent the life sciences ecosystem in B.C. which includes; academia, health institutions, research & development, SMEs, government and … Continue reading 2019 LifeSciences BC Annual Award Winners Announced

Phoenix Molecular Designs to Present at BIOCOM’s 2019 Global Life Science Partnering Conference

February 20, 2019
Phoenix Molecular Designs

VANCOUVER, British Columbia and SAN DIEGO, Feb. 20, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today that Dr. Sandra Dunn, PhoenixMD’s Chief Executive Officer, will be presenting at BIOCOM’s 2019 Global Life Science Partnering Conference being held at The Lodge at Torrey Pines in San Diego, CA. Details of the presentation … Continue reading Phoenix Molecular Designs to Present at BIOCOM’s 2019 Global Life Science Partnering Conference

DelMar Pharmaceuticals Achieves Halfway Enrollment Point for Phase 2 Clinical Trial of VAL-083 in Newly Diagnosed MGMT-unmethylated GBM

February 20, 2019
DelMar Pharmaceuticals, Inc.

 Complete Response Rate of 42% as Assessed by Principal Investigator Supports VAL-082’s Activity in GBM  VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 20, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that its Phase 2 study testing … Continue reading DelMar Pharmaceuticals Achieves Halfway Enrollment Point for Phase 2 Clinical Trial of VAL-083 in Newly Diagnosed MGMT-unmethylated GBM

GenXys Health Care Systems announces completion of oversubscribed seed round financing to launch leading precision prescribing software into the US market

February 19, 2019
GenXys Health Care Systems Inc.

GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this financing supports GenXys plans to expand into new regions to increase patient safety and … Continue reading GenXys Health Care Systems announces completion of oversubscribed seed round financing to launch leading precision prescribing software into the US market

The National Research Council of Canada and Aspect Biosystems work toward new ways to deliver therapeutics to the brain, the holy grail of biopharmaceutical sciences

February 13, 2019
Aspect Biosystems Inc.

New 3D therapeutic models of the blood-brain barrier could lead to improved treatments for Alzheimer’s, ALS, and other central nervous system diseases February 13, 2019 – Ottawa, Ontario – As diseases of the central nervous system, such as Alzheimer’s disease, continue to impact the lives of Canadians, the National Research Council of Canada (NRC) and Aspect … Continue reading The National Research Council of Canada and Aspect Biosystems work toward new ways to deliver therapeutics to the brain, the holy grail of biopharmaceutical sciences

NZTech Announces Sale of TIPSO Image Navigation Systems to The Hospital for Sick Children

February 13, 2019
NZ Technologies Inc.

VANCOUVER, British Columbia–(BUSINESS WIRE)–NZ Technologies Inc. (NZTech) is pleased to announce the sale of two TIPSO Touchless Image Navigation systems to The Hospital for Sick Children (SickKids) in Toronto, Ontario. TIPSOTM is a revolutionary technology platform invented, developed, and manufactured by NZTech. Using proprietary sensors that monitor the three-dimensional (3D) space around the surgery bed, TIPSO enables physicians to … Continue reading NZTech Announces Sale of TIPSO Image Navigation Systems to The Hospital for Sick Children

DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2019 Financial Results

February 12, 2019
DelMar Pharmaceuticals, Inc.

Company will host a business update conference call on February 19, 2019 at 4:30 PM Eastern Time VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 12, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced its financial results for the second quarter ended … Continue reading DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2019 Financial Results

CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

February 11, 2019
CDRD

CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial Vancouver, Canada – February 11, 2019: CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with a $1.2M investment. This new investment will enable Sitka and its partner Cancer Research UK (CRUK) to accelerate critical … Continue reading CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

DelMar Pharmaceuticals Receives Nasdaq Listing Extension

February 7, 2019
DelMar Pharmaceuticals, Inc.

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 7, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced that it has received a listing extension from the Nasdaq Hearings Panel.  The extension grants the Company until June 25, 2019 to regain compliance with the … Continue reading DelMar Pharmaceuticals Receives Nasdaq Listing Extension

UBC appoints Robin Ciceri as the new Vice-President, External Relations

January 31, 2019
University of British Columbia

UNIVERSITY NEWS Jan 31, 2019    |   For more information, contact Matthew Ramsey The University of British Columbia has appointed Robin Ciceri as the new Vice-President, External Relations, effective March 1, 2019. Ciceri brings to the role extensive senior leadership experience within the B.C. post-secondary system and the Government of British Columbia. In her new role, Ciceri will … Continue reading UBC appoints Robin Ciceri as the new Vice-President, External Relations